INFLAMMATORY AND ENDOCRINE MECHANISMS LINKING PEDIATRIC OBESITY TO INSULIN RESISTANCE
DOI:
https://doi.org/10.37547/Keywords:
Pediatric obesity, insulin resistance, inflammation, adipokines, cytokines, endocrine dysfunction, metabolic syndrome, TNF-alpha, adiponectin, leptin.Abstract
Pediatric obesity has emerged as a major global health concern, closely associated with the early development of metabolic disorders. Among these, insulin resistance represents a central pathophysiological mechanism linking excess adiposity to type 2 diabetes and cardiometabolic complications. Increasing evidence suggests that chronic low-grade inflammation and endocrine dysregulation play pivotal roles in this process. Visceral adiposity promotes the release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which interfere with insulin signaling pathways. Simultaneously, adipokine imbalance—characterized by elevated leptin levels and reduced adiponectin concentrations—further impairs insulin sensitivity. Alterations in hypothalamic regulation, mitochondrial dysfunction, oxidative stress, and gut microbiota changes have also been implicated in the development of insulin resistance in obese children.
Downloads
References
1.Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., … Delzenne, N. M. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772.
2.Friedman, J. M. (2014). Leptin and the regulation of body weight. Nature, 395(6704), 763–770.
3.Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature, 444(7121), 860–867.
4.Kadowaki, T., & Yamauchi, T. (2005). Adiponectin and adiponectin receptors. Nature Reviews Molecular Cell Biology, 6(8), 633–646.
5.Lumeng, C. N., & Saltiel, A. R. (2011). Inflammatory links between obesity and metabolic disease. The Journal of Clinical Investigation, 121(6), 2111–2117.
6.Rains, J. L., & Jain, S. K. (2011). Oxidative stress, insulin signaling, and diabetes. Free Radical Biology and Medicine, 50(5), 567–575.
7.Reinehr, T. (2015). Inflammatory markers in obese children and adolescents. The Journal of Clinical Endocrinology & Metabolism, 100(5), 1824–1833.
8.Thaler, J. P., Yi, C. X., Schur, E. A., et al. (2012). Obesity is associated with hypothalamic injury in rodents and humans. The Journal of Clinical Investigation, 122(1), 153–162.
9.Tchernof, A., & Després, J. P. (2013). Pathophysiology of human visceral obesity: An update. Physiological Reviews, 93(1), 359–404.
10.Weiss, R., Dziura, J., Burgert, T. S., et al. (2004). Obesity and the metabolic syndrome in children and adolescents. The New England Journal of Medicine, 350(23), 2362–2374.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
